Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
Portfolio Pulse from Lekha Gupta
The article highlights the top seven mid-cap stock gainers from August 4 to August 10, 2023. Lumen Technologies, Upstart Holdings, ADMA Biologics, Sweetgreen, Veracyte, Clear Secure, and Core Scientific saw significant stock price increases due to strong second-quarter financial results and positive analyst actions.

August 11, 2024 | 7:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ADMA Biologics stock gained 52.58% after reporting better-than-expected Q2 financial results.
The better-than-expected Q2 financial results have positively impacted the stock price, reflecting strong investor sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Core Scientific shares increased 38.37% after the company announced that CoreWeave exercised an additional contract option.
The announcement of CoreWeave exercising an additional contract option has positively impacted the stock price, indicating strong business prospects.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Lumen Technologies shares jumped 113.82% after reporting strong Q2 revenue results and receiving multiple analyst upgrades and price target increases.
The significant stock price increase was driven by strong Q2 revenue results and positive analyst actions, indicating strong market confidence.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Sweetgreen stock gained 47.35% after reporting better-than-expected Q2 financial results and issuing a strong FY24 revenue outlook, with several analysts raising the price target.
The combination of strong Q2 results, a positive FY24 revenue outlook, and increased analyst price targets has driven the stock price up.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Upstart Holdings stock jumped 73.65% after reporting strong Q2 results, leading many analysts to raise their price targets.
The strong Q2 results and subsequent analyst price target increases indicate a positive outlook for the stock in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Veracyte shares escalated 46.57% after reporting better-than-expected Q2 financial results.
The better-than-expected Q2 financial results have led to a significant increase in the stock price, indicating strong investor confidence.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Clear Secure stock increased 38.83% after reporting Q2 financial results and issuing Q3 revenue guidance above estimates.
The strong Q2 results and positive Q3 revenue guidance have driven the stock price up, reflecting positive market sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100